At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Avonexdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessing Tolerability of Avonex Intramuscular Injections With a 25 Gauge Needle Versus 30 Gauge Needle
In Brief
A clinical study evaluating Avonex for Multiple Sclerosis. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate patients' views when injecting Avonex intramuscularly.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMultiple Sclerosis
CountriesUnited States
CollaboratorsBiogen
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2012
First PostedJul 2012
Primary CompletionFeb 2014
TodayJul 2026
First PostedJul 16, 2012
Enrollment StartMay 1, 2012
Primary CompletionFeb 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 14.0 years ago
Interventions
Avonexdrug
Intramuscular injection administered using 25 gauge or 30 gauge needle